We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CYH:NYSECommunity Health Systems, Inc. Analysis

Data as of 2026-03-28 - not real-time

$2.86

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Community Health Systems is trading at $2.86, well below its 20‑day ($3.17), 50‑day ($3.25) and 200‑day ($3.21) simple moving averages, indicating a bearish technical backdrop. The RSI sits at 34, hinting at oversold conditions, yet the MACD remains bearish and price is barely above the identified support of $2.83, with resistance near $3.64. Fundamentally, the stock appears extremely cheap – a trailing PE of 0.76 versus an industry average of 25 – but this discount is driven by a distressed balance sheet: $11.0 B of debt dwarfs $0.26 B of cash, book value per share is negative, and forward EPS is projected to be slightly negative. Revenue has contracted 5% year‑over‑year to $12.5 B, though same‑store net revenue grew 2.1% in the latest quarter and per‑admission revenue rose 2.4%, suggesting modest operational resilience. The company reported improved operating cash flow ($543 M) and free cash flow ($395 M) while divesting assets to trim debt, but the heavy leverage and negative equity keep risk elevated.
Overall, the stock sits at a crossroads between a potentially deep value opportunity and significant financial headwinds, with market sentiment currently leaning toward “Greed” (Fear & Greed Index 66) despite high volatility (48% 30‑day) and a beta above 1.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price hovering just above technical support
  • Bearish MACD and RSI indicating limited upside
  • Recent mixed earnings and revenue miss

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Asset divestitures expected to reduce leverage
  • Improving same‑store revenue trends
  • Significant valuation discount relative to peers

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • High debt load and negative book value limit upside
  • Healthcare sector exposure to policy and reimbursement risk
  • Potential for gradual recovery if cash‑flow improvements persist

Key Metrics & Analysis

Financial Health

Revenue Growth-4.90%
Profit Margin4.08%
P/E Ratio0.8
ROA4.96%
P/B Ratio-0.3
Op. Cash Flow$543.0M
Free Cash Flow$395.2M
Industry P/E25.0

Technical Analysis

TrendNeutral
RSI34.3
Support$2.83
Resistance$3.64
MA 20$3.17
MA 50$3.24
MA 200$3.21
MACDBearish
VolumeStable
Fear & Greed Index65.98

Valuation

Target Price$3.60
Upside/Downside25.87%
GradeUndervalued
TypeValue

Risk Assessment

Beta1.16
Volatility48.36%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.